Cogent Biosciences (COGT) Profit After Tax: 2017-2020
Historic Profit After Tax for Cogent Biosciences (COGT) over the last 4 years, with Dec 2020 value amounting to -$11.3 million.
- Cogent Biosciences' Profit After Tax fell 593.60% to -$11.3 million in Q4 2020 from the same period last year, while for Dec 2020 it was -$74.8 million, marking a year-over-year decrease of 135.00%. This contributed to the annual value of -$74.8 million for FY2020, which is 135.00% down from last year.
- Per Cogent Biosciences' latest filing, its Profit After Tax stood at -$11.3 million for Q4 2020, which was up 77.32% from -$50.0 million recorded in Q3 2020.
- In the past 5 years, Cogent Biosciences' Profit After Tax ranged from a high of $2.3 million in Q4 2019 and a low of -$50.0 million during Q3 2020.
- Moreover, its 3-year median value for Profit After Tax was -$9.6 million (2018), whereas its average is -$11.8 million.
- In the last 5 years, Cogent Biosciences' Profit After Tax skyrocketed by 126.69% in 2019 and then slumped by 593.60% in 2020.
- Quarterly analysis of 4 years shows Cogent Biosciences' Profit After Tax stood at -$6.7 million in 2017, then fell by 28.64% to -$8.6 million in 2018, then surged by 126.69% to $2.3 million in 2019, then plummeted by 593.60% to -$11.3 million in 2020.
- Its Profit After Tax was -$11.3 million in Q4 2020, compared to -$50.0 million in Q3 2020 and -$7.4 million in Q2 2020.